3 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Industries
Headquarters
Stage
Employees
Links
John A. Scarlett
View all
6 members
Dyno Therapeutics
NotCo
Biogen
91 followers
Vertex Pharmaceuticals
33 followers
Seres Therapeutics
Explore more companies